nodes	percent_of_prediction	percent_of_DWPC	metapath
Fusidic Acid—ABCB11—Daunorubicin—hematologic cancer	0.159	0.223	CbGbCtD
Fusidic Acid—ABCC2—Daunorubicin—hematologic cancer	0.0835	0.117	CbGbCtD
Fusidic Acid—ABCB11—Vinblastine—hematologic cancer	0.0675	0.0949	CbGbCtD
Fusidic Acid—ABCB11—Vincristine—hematologic cancer	0.0664	0.0933	CbGbCtD
Fusidic Acid—ABCB11—Dexamethasone—hematologic cancer	0.05	0.0703	CbGbCtD
Fusidic Acid—ABCB11—Doxorubicin—hematologic cancer	0.0415	0.0583	CbGbCtD
Fusidic Acid—ABCC2—Irinotecan—hematologic cancer	0.0399	0.0561	CbGbCtD
Fusidic Acid—ABCC2—Vinblastine—hematologic cancer	0.0355	0.0499	CbGbCtD
Fusidic Acid—ABCC2—Vincristine—hematologic cancer	0.0349	0.049	CbGbCtD
Fusidic Acid—ABCC2—Cisplatin—hematologic cancer	0.0326	0.0457	CbGbCtD
Fusidic Acid—ABCC2—Etoposide—hematologic cancer	0.032	0.0449	CbGbCtD
Fusidic Acid—ABCC2—Dexamethasone—hematologic cancer	0.0263	0.0369	CbGbCtD
Fusidic Acid—ABCC2—Doxorubicin—hematologic cancer	0.0218	0.0306	CbGbCtD
Fusidic Acid—ABCC2—Methotrexate—hematologic cancer	0.0211	0.0297	CbGbCtD
Fusidic Acid—ABCC2—Codeine and Morphine Metabolism—ABCC3—hematologic cancer	0.00166	0.0644	CbGpPWpGaD
Fusidic Acid—ABCC2—Codeine and Morphine Metabolism—UGT1A1—hematologic cancer	0.00156	0.0606	CbGpPWpGaD
Fusidic Acid—ABCB11—Farnesoid X Receptor  Pathway—NR0B2—hematologic cancer	0.00129	0.0499	CbGpPWpGaD
Fusidic Acid—ABCB11—Recycling of bile acids and salts—ABCC3—hematologic cancer	0.00126	0.0487	CbGpPWpGaD
Fusidic Acid—ABCB11—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.0012	0.0464	CbGpPWpGaD
Fusidic Acid—ABCC2—Irinotecan Pathway—UGT1A1—hematologic cancer	0.001	0.0387	CbGpPWpGaD
Fusidic Acid—ABCB11—Farnesoid X Receptor  Pathway—FGF19—hematologic cancer	0.000968	0.0375	CbGpPWpGaD
Fusidic Acid—ABCC2—Drug Induction of Bile Acid Pathway—ABCC3—hematologic cancer	0.00091	0.0353	CbGpPWpGaD
Fusidic Acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.00087	0.0337	CbGpPWpGaD
Fusidic Acid—ABCC2—Irinotecan Pathway—ABCG2—hematologic cancer	0.000867	0.0336	CbGpPWpGaD
Fusidic Acid—ABCC2—Codeine and Morphine Metabolism—ABCB1—hematologic cancer	0.000846	0.0328	CbGpPWpGaD
Fusidic Acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000688	0.0266	CbGpPWpGaD
Fusidic Acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—hematologic cancer	0.000661	0.0256	CbGpPWpGaD
Fusidic Acid—ABCB11—Bile acid and bile salt metabolism—ABCC3—hematologic cancer	0.000657	0.0254	CbGpPWpGaD
Fusidic Acid—ABCB11—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000609	0.0236	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—ABCC3—hematologic cancer	0.000549	0.0213	CbGpPWpGaD
Fusidic Acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—hematologic cancer	0.000523	0.0202	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—UGT1A1—hematologic cancer	0.000516	0.02	CbGpPWpGaD
Fusidic Acid—ABCC2—ABC-family proteins mediated transport—ABCC3—hematologic cancer	0.000499	0.0193	CbGpPWpGaD
Fusidic Acid—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—hematologic cancer	0.000463	0.0179	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—SMC1A—hematologic cancer	0.000403	0.0156	CbGpPWpGaD
Fusidic Acid—ABCB11—Recycling of bile acids and salts—ALB—hematologic cancer	0.0004	0.0155	CbGpPWpGaD
Fusidic Acid—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.00035	0.0136	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—HSP90AA1—hematologic cancer	0.000332	0.0129	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	0.000279	0.0108	CbGpPWpGaD
Fusidic Acid—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	0.000266	0.0103	CbGpPWpGaD
Fusidic Acid—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	0.000264	0.0102	CbGpPWpGaD
Fusidic Acid—ABCC2—ABC-family proteins mediated transport—ABCB1—hematologic cancer	0.000254	0.00984	CbGpPWpGaD
Fusidic Acid—ABCB11—Bile acid and bile salt metabolism—ALB—hematologic cancer	0.000209	0.0081	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000174	0.00673	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—ABCC3—hematologic cancer	0.000163	0.00631	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—TXN—hematologic cancer	0.000163	0.00631	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000159	0.00616	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—UGT1A1—hematologic cancer	0.000153	0.00593	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000115	0.00445	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000112	0.00434	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000107	0.00414	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—NQO1—hematologic cancer	0.000105	0.00407	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—HSP90AA1—hematologic cancer	9.87e-05	0.00382	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	9.13e-05	0.00354	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—GSTP1—hematologic cancer	8.76e-05	0.00339	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—S100A10—hematologic cancer	8.71e-05	0.00337	CbGpPWpGaD
Fusidic Acid—Erythema—Prednisone—hematologic cancer	8.48e-05	0.000323	CcSEcCtD
Fusidic Acid—Rash—Thiotepa—hematologic cancer	8.47e-05	0.000323	CcSEcCtD
Fusidic Acid—Dermatitis—Thiotepa—hematologic cancer	8.47e-05	0.000323	CcSEcCtD
Fusidic Acid—Diarrhoea—Alitretinoin—hematologic cancer	8.46e-05	0.000323	CcSEcCtD
Fusidic Acid—Agranulocytosis—Methotrexate—hematologic cancer	8.46e-05	0.000323	CcSEcCtD
Fusidic Acid—Headache—Thiotepa—hematologic cancer	8.42e-05	0.000321	CcSEcCtD
Fusidic Acid—Decreased appetite—Etoposide—hematologic cancer	8.39e-05	0.00032	CcSEcCtD
Fusidic Acid—Diarrhoea—Ifosfamide—hematologic cancer	8.36e-05	0.000319	CcSEcCtD
Fusidic Acid—Pancytopenia—Doxorubicin—hematologic cancer	8.36e-05	0.000319	CcSEcCtD
Fusidic Acid—Nausea—Vinorelbine—hematologic cancer	8.36e-05	0.000319	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Etoposide—hematologic cancer	8.33e-05	0.000318	CcSEcCtD
Fusidic Acid—Jaundice—Epirubicin—hematologic cancer	8.27e-05	0.000315	CcSEcCtD
Fusidic Acid—Vomiting—Thalidomide—hematologic cancer	8.26e-05	0.000315	CcSEcCtD
Fusidic Acid—Dizziness—Carmustine—hematologic cancer	8.25e-05	0.000315	CcSEcCtD
Fusidic Acid—Pain—Etoposide—hematologic cancer	8.25e-05	0.000315	CcSEcCtD
Fusidic Acid—Conjunctivitis—Epirubicin—hematologic cancer	8.25e-05	0.000314	CcSEcCtD
Fusidic Acid—Neutropenia—Doxorubicin—hematologic cancer	8.23e-05	0.000314	CcSEcCtD
Fusidic Acid—Rash—Thalidomide—hematologic cancer	8.2e-05	0.000312	CcSEcCtD
Fusidic Acid—Discomfort—Dexamethasone—hematologic cancer	8.19e-05	0.000312	CcSEcCtD
Fusidic Acid—Discomfort—Betamethasone—hematologic cancer	8.19e-05	0.000312	CcSEcCtD
Fusidic Acid—Dermatitis—Thalidomide—hematologic cancer	8.19e-05	0.000312	CcSEcCtD
Fusidic Acid—Dizziness—Alitretinoin—hematologic cancer	8.18e-05	0.000312	CcSEcCtD
Fusidic Acid—Diarrhoea—Vincristine—hematologic cancer	8.15e-05	0.000311	CcSEcCtD
Fusidic Acid—Headache—Thalidomide—hematologic cancer	8.14e-05	0.00031	CcSEcCtD
Fusidic Acid—Pain—Prednisolone—hematologic cancer	8.14e-05	0.00031	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	8.1e-05	0.00314	CbGpPWpGaD
Fusidic Acid—Dizziness—Ifosfamide—hematologic cancer	8.08e-05	0.000308	CcSEcCtD
Fusidic Acid—ABCC2—NRF2 pathway—HGF—hematologic cancer	8.05e-05	0.00312	CbGpPWpGaD
Fusidic Acid—ABCC2—NRF2 pathway—GSTM1—hematologic cancer	8.05e-05	0.00312	CbGpPWpGaD
Fusidic Acid—Hepatobiliary disease—Epirubicin—hematologic cancer	8.02e-05	0.000306	CcSEcCtD
Fusidic Acid—Pruritus—Gemcitabine—hematologic cancer	8e-05	0.000305	CcSEcCtD
Fusidic Acid—Vision blurred—Prednisone—hematologic cancer	7.99e-05	0.000305	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	7.98e-05	0.00309	CbGpPWpGaD
Fusidic Acid—Nausea—Thiotepa—hematologic cancer	7.98e-05	0.000304	CcSEcCtD
Fusidic Acid—Diarrhoea—Mitoxantrone—hematologic cancer	7.94e-05	0.000303	CcSEcCtD
Fusidic Acid—Diarrhoea—Irinotecan—hematologic cancer	7.94e-05	0.000303	CcSEcCtD
Fusidic Acid—Vomiting—Carmustine—hematologic cancer	7.94e-05	0.000303	CcSEcCtD
Fusidic Acid—Agranulocytosis—Epirubicin—hematologic cancer	7.92e-05	0.000302	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Etoposide—hematologic cancer	7.89e-05	0.000301	CcSEcCtD
Fusidic Acid—Dizziness—Vincristine—hematologic cancer	7.88e-05	0.0003	CcSEcCtD
Fusidic Acid—Rash—Carmustine—hematologic cancer	7.87e-05	0.0003	CcSEcCtD
Fusidic Acid—Dermatitis—Carmustine—hematologic cancer	7.86e-05	0.0003	CcSEcCtD
Fusidic Acid—Vomiting—Alitretinoin—hematologic cancer	7.86e-05	0.0003	CcSEcCtD
Fusidic Acid—Anaemia—Prednisone—hematologic cancer	7.84e-05	0.000299	CcSEcCtD
Fusidic Acid—Headache—Carmustine—hematologic cancer	7.82e-05	0.000298	CcSEcCtD
Fusidic Acid—Rash—Alitretinoin—hematologic cancer	7.8e-05	0.000297	CcSEcCtD
Fusidic Acid—Dermatitis—Alitretinoin—hematologic cancer	7.79e-05	0.000297	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Betamethasone—hematologic cancer	7.78e-05	0.000297	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Dexamethasone—hematologic cancer	7.78e-05	0.000297	CcSEcCtD
Fusidic Acid—Vomiting—Ifosfamide—hematologic cancer	7.77e-05	0.000296	CcSEcCtD
Fusidic Acid—Hypersensitivity—Cisplatin—hematologic cancer	7.76e-05	0.000296	CcSEcCtD
Fusidic Acid—Headache—Alitretinoin—hematologic cancer	7.75e-05	0.000295	CcSEcCtD
Fusidic Acid—Angioedema—Prednisone—hematologic cancer	7.75e-05	0.000295	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—FTCD—hematologic cancer	7.74e-05	0.003	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PHYH—hematologic cancer	7.74e-05	0.003	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—GMPS—hematologic cancer	7.74e-05	0.003	CbGpPWpGaD
Fusidic Acid—Diarrhoea—Gemcitabine—hematologic cancer	7.73e-05	0.000295	CcSEcCtD
Fusidic Acid—Nausea—Thalidomide—hematologic cancer	7.72e-05	0.000294	CcSEcCtD
Fusidic Acid—Dyspepsia—Triamcinolone—hematologic cancer	7.71e-05	0.000294	CcSEcCtD
Fusidic Acid—Rash—Ifosfamide—hematologic cancer	7.71e-05	0.000294	CcSEcCtD
Fusidic Acid—Dermatitis—Ifosfamide—hematologic cancer	7.7e-05	0.000294	CcSEcCtD
Fusidic Acid—Dizziness—Irinotecan—hematologic cancer	7.67e-05	0.000293	CcSEcCtD
Fusidic Acid—Urticaria—Etoposide—hematologic cancer	7.67e-05	0.000292	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	7.67e-05	0.00297	CbGpPWpGaD
Fusidic Acid—Jaundice—Doxorubicin—hematologic cancer	7.65e-05	0.000292	CcSEcCtD
Fusidic Acid—Abdominal pain—Etoposide—hematologic cancer	7.63e-05	0.000291	CcSEcCtD
Fusidic Acid—Conjunctivitis—Doxorubicin—hematologic cancer	7.63e-05	0.000291	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	7.61e-05	0.00295	CbGpPWpGaD
Fusidic Acid—Eye disorder—Methotrexate—hematologic cancer	7.61e-05	0.00029	CcSEcCtD
Fusidic Acid—Vomiting—Vincristine—hematologic cancer	7.58e-05	0.000289	CcSEcCtD
Fusidic Acid—Anorexia—Betamethasone—hematologic cancer	7.57e-05	0.000289	CcSEcCtD
Fusidic Acid—Anorexia—Dexamethasone—hematologic cancer	7.57e-05	0.000289	CcSEcCtD
Fusidic Acid—Urticaria—Prednisolone—hematologic cancer	7.56e-05	0.000288	CcSEcCtD
Fusidic Acid—Rash—Vincristine—hematologic cancer	7.51e-05	0.000286	CcSEcCtD
Fusidic Acid—Dermatitis—Vincristine—hematologic cancer	7.51e-05	0.000286	CcSEcCtD
Fusidic Acid—Pain—Triamcinolone—hematologic cancer	7.49e-05	0.000285	CcSEcCtD
Fusidic Acid—Headache—Vincristine—hematologic cancer	7.47e-05	0.000285	CcSEcCtD
Fusidic Acid—Hepatobiliary disease—Doxorubicin—hematologic cancer	7.42e-05	0.000283	CcSEcCtD
Fusidic Acid—Nausea—Carmustine—hematologic cancer	7.41e-05	0.000283	CcSEcCtD
Fusidic Acid—Vomiting—Mitoxantrone—hematologic cancer	7.38e-05	0.000281	CcSEcCtD
Fusidic Acid—Vomiting—Irinotecan—hematologic cancer	7.38e-05	0.000281	CcSEcCtD
Fusidic Acid—Immune system disorder—Methotrexate—hematologic cancer	7.35e-05	0.00028	CcSEcCtD
Fusidic Acid—Nausea—Alitretinoin—hematologic cancer	7.35e-05	0.00028	CcSEcCtD
Fusidic Acid—Agranulocytosis—Doxorubicin—hematologic cancer	7.33e-05	0.000279	CcSEcCtD
Fusidic Acid—Rash—Irinotecan—hematologic cancer	7.32e-05	0.000279	CcSEcCtD
Fusidic Acid—Rash—Mitoxantrone—hematologic cancer	7.32e-05	0.000279	CcSEcCtD
Fusidic Acid—Dermatitis—Irinotecan—hematologic cancer	7.31e-05	0.000279	CcSEcCtD
Fusidic Acid—Dermatitis—Mitoxantrone—hematologic cancer	7.31e-05	0.000279	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	7.3e-05	0.00283	CbGpPWpGaD
Fusidic Acid—Headache—Irinotecan—hematologic cancer	7.27e-05	0.000277	CcSEcCtD
Fusidic Acid—Headache—Mitoxantrone—hematologic cancer	7.27e-05	0.000277	CcSEcCtD
Fusidic Acid—Nausea—Ifosfamide—hematologic cancer	7.26e-05	0.000277	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	7.22e-05	0.0028	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	7.22e-05	0.0028	CbGpPWpGaD
Fusidic Acid—Diarrhoea—Cisplatin—hematologic cancer	7.21e-05	0.000275	CcSEcCtD
Fusidic Acid—Vomiting—Gemcitabine—hematologic cancer	7.19e-05	0.000274	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	7.17e-05	0.000273	CcSEcCtD
Fusidic Acid—Discomfort—Prednisone—hematologic cancer	7.13e-05	0.000272	CcSEcCtD
Fusidic Acid—Rash—Gemcitabine—hematologic cancer	7.13e-05	0.000272	CcSEcCtD
Fusidic Acid—Dermatitis—Gemcitabine—hematologic cancer	7.12e-05	0.000271	CcSEcCtD
Fusidic Acid—Eye disorder—Epirubicin—hematologic cancer	7.12e-05	0.000271	CcSEcCtD
Fusidic Acid—Hypersensitivity—Etoposide—hematologic cancer	7.11e-05	0.000271	CcSEcCtD
Fusidic Acid—Erythema—Methotrexate—hematologic cancer	7.08e-05	0.00027	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—SMPD3—hematologic cancer	7.08e-05	0.00274	CbGpPWpGaD
Fusidic Acid—Headache—Gemcitabine—hematologic cancer	7.08e-05	0.00027	CcSEcCtD
Fusidic Acid—Nausea—Vincristine—hematologic cancer	7.08e-05	0.00027	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	7.07e-05	0.00274	CbGpPWpGaD
Fusidic Acid—Hypersensitivity—Prednisolone—hematologic cancer	7.01e-05	0.000267	CcSEcCtD
Fusidic Acid—Dyspepsia—Betamethasone—hematologic cancer	6.99e-05	0.000267	CcSEcCtD
Fusidic Acid—Dyspepsia—Dexamethasone—hematologic cancer	6.99e-05	0.000267	CcSEcCtD
Fusidic Acid—Urticaria—Triamcinolone—hematologic cancer	6.96e-05	0.000265	CcSEcCtD
Fusidic Acid—ABCC2—NRF2 pathway—PDGFB—hematologic cancer	6.92e-05	0.00268	CbGpPWpGaD
Fusidic Acid—Decreased appetite—Betamethasone—hematologic cancer	6.91e-05	0.000263	CcSEcCtD
Fusidic Acid—Decreased appetite—Dexamethasone—hematologic cancer	6.91e-05	0.000263	CcSEcCtD
Fusidic Acid—Nausea—Mitoxantrone—hematologic cancer	6.89e-05	0.000263	CcSEcCtD
Fusidic Acid—Nausea—Irinotecan—hematologic cancer	6.89e-05	0.000263	CcSEcCtD
Fusidic Acid—Immune system disorder—Epirubicin—hematologic cancer	6.88e-05	0.000262	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Betamethasone—hematologic cancer	6.86e-05	0.000261	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Dexamethasone—hematologic cancer	6.86e-05	0.000261	CcSEcCtD
Fusidic Acid—Pruritus—Etoposide—hematologic cancer	6.83e-05	0.00026	CcSEcCtD
Fusidic Acid—Arrhythmia—Epirubicin—hematologic cancer	6.8e-05	0.000259	CcSEcCtD
Fusidic Acid—Pain—Betamethasone—hematologic cancer	6.79e-05	0.000259	CcSEcCtD
Fusidic Acid—Pain—Dexamethasone—hematologic cancer	6.79e-05	0.000259	CcSEcCtD
Fusidic Acid—Skin disorder—Prednisone—hematologic cancer	6.72e-05	0.000256	CcSEcCtD
Fusidic Acid—Nausea—Gemcitabine—hematologic cancer	6.71e-05	0.000256	CcSEcCtD
Fusidic Acid—Vomiting—Cisplatin—hematologic cancer	6.7e-05	0.000255	CcSEcCtD
Fusidic Acid—Vision blurred—Methotrexate—hematologic cancer	6.68e-05	0.000255	CcSEcCtD
Fusidic Acid—Rash—Cisplatin—hematologic cancer	6.64e-05	0.000253	CcSEcCtD
Fusidic Acid—Dermatitis—Cisplatin—hematologic cancer	6.64e-05	0.000253	CcSEcCtD
Fusidic Acid—Erythema—Epirubicin—hematologic cancer	6.63e-05	0.000253	CcSEcCtD
Fusidic Acid—Diarrhoea—Etoposide—hematologic cancer	6.6e-05	0.000252	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	6.6e-05	0.00256	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	6.6e-05	0.00256	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—SGK1—hematologic cancer	6.6e-05	0.00256	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	6.6e-05	0.00256	CbGpPWpGaD
Fusidic Acid—Anorexia—Prednisone—hematologic cancer	6.6e-05	0.000251	CcSEcCtD
Fusidic Acid—Eye disorder—Doxorubicin—hematologic cancer	6.59e-05	0.000251	CcSEcCtD
Fusidic Acid—Anaemia—Methotrexate—hematologic cancer	6.55e-05	0.00025	CcSEcCtD
Fusidic Acid—Flatulence—Epirubicin—hematologic cancer	6.53e-05	0.000249	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Betamethasone—hematologic cancer	6.5e-05	0.000248	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Dexamethasone—hematologic cancer	6.5e-05	0.000248	CcSEcCtD
Fusidic Acid—Hypersensitivity—Triamcinolone—hematologic cancer	6.45e-05	0.000246	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	6.44e-05	0.00249	CbGpPWpGaD
Fusidic Acid—Dizziness—Etoposide—hematologic cancer	6.38e-05	0.000243	CcSEcCtD
Fusidic Acid—Immune system disorder—Doxorubicin—hematologic cancer	6.37e-05	0.000243	CcSEcCtD
Fusidic Acid—Leukopenia—Methotrexate—hematologic cancer	6.34e-05	0.000242	CcSEcCtD
Fusidic Acid—Urticaria—Dexamethasone—hematologic cancer	6.31e-05	0.000241	CcSEcCtD
Fusidic Acid—Urticaria—Betamethasone—hematologic cancer	6.31e-05	0.000241	CcSEcCtD
Fusidic Acid—Dizziness—Prednisolone—hematologic cancer	6.3e-05	0.00024	CcSEcCtD
Fusidic Acid—Arrhythmia—Doxorubicin—hematologic cancer	6.3e-05	0.00024	CcSEcCtD
Fusidic Acid—Abdominal pain—Dexamethasone—hematologic cancer	6.28e-05	0.000239	CcSEcCtD
Fusidic Acid—Abdominal pain—Betamethasone—hematologic cancer	6.28e-05	0.000239	CcSEcCtD
Fusidic Acid—Nausea—Cisplatin—hematologic cancer	6.26e-05	0.000239	CcSEcCtD
Fusidic Acid—Vision blurred—Epirubicin—hematologic cancer	6.25e-05	0.000238	CcSEcCtD
Fusidic Acid—Pruritus—Triamcinolone—hematologic cancer	6.19e-05	0.000236	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—B3GAT1—hematologic cancer	6.19e-05	0.0024	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ASNS—hematologic cancer	6.19e-05	0.0024	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—DCK—hematologic cancer	6.19e-05	0.0024	CbGpPWpGaD
Fusidic Acid—Vomiting—Etoposide—hematologic cancer	6.14e-05	0.000234	CcSEcCtD
Fusidic Acid—Erythema—Doxorubicin—hematologic cancer	6.13e-05	0.000234	CcSEcCtD
Fusidic Acid—Anaemia—Epirubicin—hematologic cancer	6.13e-05	0.000234	CcSEcCtD
Fusidic Acid—Dyspepsia—Prednisone—hematologic cancer	6.09e-05	0.000232	CcSEcCtD
Fusidic Acid—Rash—Etoposide—hematologic cancer	6.09e-05	0.000232	CcSEcCtD
Fusidic Acid—Dermatitis—Etoposide—hematologic cancer	6.08e-05	0.000232	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	6.05e-05	0.00234	CbGpPWpGaD
Fusidic Acid—Headache—Etoposide—hematologic cancer	6.05e-05	0.000231	CcSEcCtD
Fusidic Acid—Flatulence—Doxorubicin—hematologic cancer	6.05e-05	0.00023	CcSEcCtD
Fusidic Acid—Decreased appetite—Prednisone—hematologic cancer	6.01e-05	0.000229	CcSEcCtD
Fusidic Acid—Rash—Prednisolone—hematologic cancer	6e-05	0.000229	CcSEcCtD
Fusidic Acid—Dermatitis—Prednisolone—hematologic cancer	6e-05	0.000229	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.99e-05	0.000228	CcSEcCtD
Fusidic Acid—Headache—Prednisolone—hematologic cancer	5.96e-05	0.000227	CcSEcCtD
Fusidic Acid—Discomfort—Methotrexate—hematologic cancer	5.96e-05	0.000227	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	5.94e-05	0.0023	CbGpPWpGaD
Fusidic Acid—Leukopenia—Epirubicin—hematologic cancer	5.93e-05	0.000226	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—HDC—hematologic cancer	5.87e-05	0.00227	CbGpPWpGaD
Fusidic Acid—Dizziness—Triamcinolone—hematologic cancer	5.79e-05	0.000221	CcSEcCtD
Fusidic Acid—Vision blurred—Doxorubicin—hematologic cancer	5.78e-05	0.00022	CcSEcCtD
Fusidic Acid—Nausea—Etoposide—hematologic cancer	5.73e-05	0.000219	CcSEcCtD
Fusidic Acid—Anaemia—Doxorubicin—hematologic cancer	5.67e-05	0.000216	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Methotrexate—hematologic cancer	5.66e-05	0.000216	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Prednisone—hematologic cancer	5.66e-05	0.000216	CcSEcCtD
Fusidic Acid—Nausea—Prednisolone—hematologic cancer	5.66e-05	0.000216	CcSEcCtD
Fusidic Acid—Pruritus—Dexamethasone—hematologic cancer	5.62e-05	0.000214	CcSEcCtD
Fusidic Acid—Pruritus—Betamethasone—hematologic cancer	5.62e-05	0.000214	CcSEcCtD
Fusidic Acid—Skin disorder—Methotrexate—hematologic cancer	5.62e-05	0.000214	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	5.61e-05	0.000214	CcSEcCtD
Fusidic Acid—Discomfort—Epirubicin—hematologic cancer	5.58e-05	0.000213	CcSEcCtD
Fusidic Acid—Vomiting—Triamcinolone—hematologic cancer	5.57e-05	0.000212	CcSEcCtD
Fusidic Acid—Rash—Triamcinolone—hematologic cancer	5.52e-05	0.00021	CcSEcCtD
Fusidic Acid—Dermatitis—Triamcinolone—hematologic cancer	5.52e-05	0.00021	CcSEcCtD
Fusidic Acid—Anorexia—Methotrexate—hematologic cancer	5.51e-05	0.00021	CcSEcCtD
Fusidic Acid—Urticaria—Prednisone—hematologic cancer	5.5e-05	0.00021	CcSEcCtD
Fusidic Acid—Leukopenia—Doxorubicin—hematologic cancer	5.49e-05	0.000209	CcSEcCtD
Fusidic Acid—Headache—Triamcinolone—hematologic cancer	5.49e-05	0.000209	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	5.47e-05	0.00212	CbGpPWpGaD
Fusidic Acid—Abdominal pain—Prednisone—hematologic cancer	5.47e-05	0.000209	CcSEcCtD
Fusidic Acid—Diarrhoea—Dexamethasone—hematologic cancer	5.44e-05	0.000207	CcSEcCtD
Fusidic Acid—Diarrhoea—Betamethasone—hematologic cancer	5.44e-05	0.000207	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—CDA—hematologic cancer	5.37e-05	0.00208	CbGpPWpGaD
Fusidic Acid—Thrombocytopenia—Epirubicin—hematologic cancer	5.3e-05	0.000202	CcSEcCtD
Fusidic Acid—Skin disorder—Epirubicin—hematologic cancer	5.26e-05	0.0002	CcSEcCtD
Fusidic Acid—Dizziness—Dexamethasone—hematologic cancer	5.25e-05	0.0002	CcSEcCtD
Fusidic Acid—Dizziness—Betamethasone—hematologic cancer	5.25e-05	0.0002	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	5.22e-05	0.00202	CbGpPWpGaD
Fusidic Acid—Nausea—Triamcinolone—hematologic cancer	5.2e-05	0.000198	CcSEcCtD
Fusidic Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	5.19e-05	0.000198	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—PC—hematologic cancer	5.17e-05	0.002	CbGpPWpGaD
Fusidic Acid—Discomfort—Doxorubicin—hematologic cancer	5.16e-05	0.000197	CcSEcCtD
Fusidic Acid—Anorexia—Epirubicin—hematologic cancer	5.16e-05	0.000197	CcSEcCtD
Fusidic Acid—Hypersensitivity—Prednisone—hematologic cancer	5.1e-05	0.000194	CcSEcCtD
Fusidic Acid—Dyspepsia—Methotrexate—hematologic cancer	5.09e-05	0.000194	CcSEcCtD
Fusidic Acid—Vomiting—Dexamethasone—hematologic cancer	5.05e-05	0.000193	CcSEcCtD
Fusidic Acid—Vomiting—Betamethasone—hematologic cancer	5.05e-05	0.000193	CcSEcCtD
Fusidic Acid—Decreased appetite—Methotrexate—hematologic cancer	5.03e-05	0.000192	CcSEcCtD
Fusidic Acid—Rash—Dexamethasone—hematologic cancer	5.01e-05	0.000191	CcSEcCtD
Fusidic Acid—Rash—Betamethasone—hematologic cancer	5.01e-05	0.000191	CcSEcCtD
Fusidic Acid—Dermatitis—Dexamethasone—hematologic cancer	5e-05	0.000191	CcSEcCtD
Fusidic Acid—Dermatitis—Betamethasone—hematologic cancer	5e-05	0.000191	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.99e-05	0.00019	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—GBA—hematologic cancer	4.99e-05	0.00193	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—SLC35B2—hematologic cancer	4.99e-05	0.00193	CbGpPWpGaD
Fusidic Acid—Headache—Dexamethasone—hematologic cancer	4.98e-05	0.00019	CcSEcCtD
Fusidic Acid—Headache—Betamethasone—hematologic cancer	4.98e-05	0.00019	CcSEcCtD
Fusidic Acid—Pain—Methotrexate—hematologic cancer	4.94e-05	0.000189	CcSEcCtD
Fusidic Acid—Thrombocytopenia—Doxorubicin—hematologic cancer	4.9e-05	0.000187	CcSEcCtD
Fusidic Acid—Pruritus—Prednisone—hematologic cancer	4.89e-05	0.000187	CcSEcCtD
Fusidic Acid—Skin disorder—Doxorubicin—hematologic cancer	4.86e-05	0.000185	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4.77e-05	0.00185	CbGpPWpGaD
Fusidic Acid—Anorexia—Doxorubicin—hematologic cancer	4.77e-05	0.000182	CcSEcCtD
Fusidic Acid—Dyspepsia—Epirubicin—hematologic cancer	4.76e-05	0.000182	CcSEcCtD
Fusidic Acid—Diarrhoea—Prednisone—hematologic cancer	4.73e-05	0.00018	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Methotrexate—hematologic cancer	4.73e-05	0.00018	CcSEcCtD
Fusidic Acid—Nausea—Dexamethasone—hematologic cancer	4.72e-05	0.00018	CcSEcCtD
Fusidic Acid—Nausea—Betamethasone—hematologic cancer	4.72e-05	0.00018	CcSEcCtD
Fusidic Acid—Decreased appetite—Epirubicin—hematologic cancer	4.7e-05	0.000179	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.67e-05	0.000178	CcSEcCtD
Fusidic Acid—Pain—Epirubicin—hematologic cancer	4.63e-05	0.000176	CcSEcCtD
Fusidic Acid—Urticaria—Methotrexate—hematologic cancer	4.59e-05	0.000175	CcSEcCtD
Fusidic Acid—Dizziness—Prednisone—hematologic cancer	4.58e-05	0.000174	CcSEcCtD
Fusidic Acid—Abdominal pain—Methotrexate—hematologic cancer	4.57e-05	0.000174	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—MTAP—hematologic cancer	4.56e-05	0.00177	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	4.5e-05	0.00174	CbGpPWpGaD
Fusidic Acid—Gastrointestinal pain—Epirubicin—hematologic cancer	4.42e-05	0.000169	CcSEcCtD
Fusidic Acid—Dyspepsia—Doxorubicin—hematologic cancer	4.41e-05	0.000168	CcSEcCtD
Fusidic Acid—Vomiting—Prednisone—hematologic cancer	4.4e-05	0.000168	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	4.37e-05	0.00169	CbGpPWpGaD
Fusidic Acid—Rash—Prednisone—hematologic cancer	4.36e-05	0.000166	CcSEcCtD
Fusidic Acid—Dermatitis—Prednisone—hematologic cancer	4.36e-05	0.000166	CcSEcCtD
Fusidic Acid—Decreased appetite—Doxorubicin—hematologic cancer	4.35e-05	0.000166	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	4.34e-05	0.00168	CbGpPWpGaD
Fusidic Acid—Headache—Prednisone—hematologic cancer	4.33e-05	0.000165	CcSEcCtD
Fusidic Acid—Gastrointestinal disorder—Doxorubicin—hematologic cancer	4.32e-05	0.000165	CcSEcCtD
Fusidic Acid—Urticaria—Epirubicin—hematologic cancer	4.3e-05	0.000164	CcSEcCtD
Fusidic Acid—Pain—Doxorubicin—hematologic cancer	4.28e-05	0.000163	CcSEcCtD
Fusidic Acid—Abdominal pain—Epirubicin—hematologic cancer	4.28e-05	0.000163	CcSEcCtD
Fusidic Acid—Hypersensitivity—Methotrexate—hematologic cancer	4.26e-05	0.000162	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.25e-05	0.00165	CbGpPWpGaD
Fusidic Acid—Nausea—Prednisone—hematologic cancer	4.11e-05	0.000157	CcSEcCtD
Fusidic Acid—Gastrointestinal pain—Doxorubicin—hematologic cancer	4.09e-05	0.000156	CcSEcCtD
Fusidic Acid—Pruritus—Methotrexate—hematologic cancer	4.09e-05	0.000156	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—FHL2—hematologic cancer	4.07e-05	0.00158	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—AGRN—hematologic cancer	3.99e-05	0.00154	CbGpPWpGaD
Fusidic Acid—Hypersensitivity—Epirubicin—hematologic cancer	3.99e-05	0.000152	CcSEcCtD
Fusidic Acid—Urticaria—Doxorubicin—hematologic cancer	3.98e-05	0.000152	CcSEcCtD
Fusidic Acid—Abdominal pain—Doxorubicin—hematologic cancer	3.96e-05	0.000151	CcSEcCtD
Fusidic Acid—Diarrhoea—Methotrexate—hematologic cancer	3.96e-05	0.000151	CcSEcCtD
Fusidic Acid—Pruritus—Epirubicin—hematologic cancer	3.83e-05	0.000146	CcSEcCtD
Fusidic Acid—Dizziness—Methotrexate—hematologic cancer	3.82e-05	0.000146	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.79e-05	0.00147	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—HMMR—hematologic cancer	3.78e-05	0.00146	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—IDH2—hematologic cancer	3.78e-05	0.00146	CbGpPWpGaD
Fusidic Acid—Diarrhoea—Epirubicin—hematologic cancer	3.7e-05	0.000141	CcSEcCtD
Fusidic Acid—Hypersensitivity—Doxorubicin—hematologic cancer	3.69e-05	0.000141	CcSEcCtD
Fusidic Acid—Vomiting—Methotrexate—hematologic cancer	3.68e-05	0.00014	CcSEcCtD
Fusidic Acid—Rash—Methotrexate—hematologic cancer	3.65e-05	0.000139	CcSEcCtD
Fusidic Acid—Dermatitis—Methotrexate—hematologic cancer	3.64e-05	0.000139	CcSEcCtD
Fusidic Acid—Headache—Methotrexate—hematologic cancer	3.62e-05	0.000138	CcSEcCtD
Fusidic Acid—Dizziness—Epirubicin—hematologic cancer	3.58e-05	0.000136	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.57e-05	0.00138	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ARNTL—hematologic cancer	3.56e-05	0.00138	CbGpPWpGaD
Fusidic Acid—Pruritus—Doxorubicin—hematologic cancer	3.54e-05	0.000135	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—ACP5—hematologic cancer	3.46e-05	0.00134	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—CA9—hematologic cancer	3.46e-05	0.00134	CbGpPWpGaD
Fusidic Acid—Vomiting—Epirubicin—hematologic cancer	3.44e-05	0.000131	CcSEcCtD
Fusidic Acid—Nausea—Methotrexate—hematologic cancer	3.43e-05	0.000131	CcSEcCtD
Fusidic Acid—Diarrhoea—Doxorubicin—hematologic cancer	3.43e-05	0.000131	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—NCOR2—hematologic cancer	3.41e-05	0.00132	CbGpPWpGaD
Fusidic Acid—Rash—Epirubicin—hematologic cancer	3.41e-05	0.00013	CcSEcCtD
Fusidic Acid—Dermatitis—Epirubicin—hematologic cancer	3.41e-05	0.00013	CcSEcCtD
Fusidic Acid—Headache—Epirubicin—hematologic cancer	3.39e-05	0.000129	CcSEcCtD
Fusidic Acid—Dizziness—Doxorubicin—hematologic cancer	3.31e-05	0.000126	CcSEcCtD
Fusidic Acid—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	3.28e-05	0.00127	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—IDH1—hematologic cancer	3.25e-05	0.00126	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ABCC3—hematologic cancer	3.22e-05	0.00125	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—GSTO1—hematologic cancer	3.22e-05	0.00125	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—TXN—hematologic cancer	3.22e-05	0.00125	CbGpPWpGaD
Fusidic Acid—Nausea—Epirubicin—hematologic cancer	3.21e-05	0.000123	CcSEcCtD
Fusidic Acid—Vomiting—Doxorubicin—hematologic cancer	3.18e-05	0.000121	CcSEcCtD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.18e-05	0.00123	CbGpPWpGaD
Fusidic Acid—Rash—Doxorubicin—hematologic cancer	3.16e-05	0.00012	CcSEcCtD
Fusidic Acid—Dermatitis—Doxorubicin—hematologic cancer	3.15e-05	0.00012	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—SPHK1—hematologic cancer	3.15e-05	0.00122	CbGpPWpGaD
Fusidic Acid—Headache—Doxorubicin—hematologic cancer	3.14e-05	0.00012	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—UGT1A1—hematologic cancer	3.02e-05	0.00117	CbGpPWpGaD
Fusidic Acid—Nausea—Doxorubicin—hematologic cancer	2.97e-05	0.000113	CcSEcCtD
Fusidic Acid—ABCB11—Metabolism—SLC22A1—hematologic cancer	2.94e-05	0.00114	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—CRABP1—hematologic cancer	2.94e-05	0.00114	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ALOX5—hematologic cancer	2.87e-05	0.00111	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—NUP98—hematologic cancer	2.78e-05	0.00108	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ADCY7—hematologic cancer	2.69e-05	0.00104	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—NCOA3—hematologic cancer	2.69e-05	0.00104	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—NUP214—hematologic cancer	2.68e-05	0.00104	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.65e-05	0.00103	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.65e-05	0.00103	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ABCG2—hematologic cancer	2.62e-05	0.00102	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—MTR—hematologic cancer	2.62e-05	0.00102	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ENO2—hematologic cancer	2.57e-05	0.000996	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—GSTT1—hematologic cancer	2.49e-05	0.000966	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.46e-05	0.000951	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—SDC1—hematologic cancer	2.44e-05	0.000944	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.33e-05	0.000902	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.3e-05	0.00089	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.2e-05	0.000851	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—NQO1—hematologic cancer	2.07e-05	0.000803	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—CD44—hematologic cancer	2.07e-05	0.000803	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.03e-05	0.000786	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—CYCS—hematologic cancer	1.96e-05	0.000759	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—HSP90AA1—hematologic cancer	1.95e-05	0.000755	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.77e-05	0.000687	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.75e-05	0.000679	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—GSTP1—hematologic cancer	1.73e-05	0.000669	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.67e-05	0.000648	CbGpPWpGaD
Fusidic Acid—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.66e-05	0.000643	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ABCB1—hematologic cancer	1.64e-05	0.000634	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—NCOR1—hematologic cancer	1.59e-05	0.000615	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—GSTM1—hematologic cancer	1.59e-05	0.000615	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—MTHFR—hematologic cancer	1.4e-05	0.000544	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.24e-05	0.000479	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PIK3CG—hematologic cancer	1.18e-05	0.000457	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—CREBBP—hematologic cancer	1.09e-05	0.000423	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PIK3CD—hematologic cancer	1.04e-05	0.000401	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—ALB—hematologic cancer	1.02e-05	0.000396	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PIK3R1—hematologic cancer	9.79e-06	0.000379	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PIK3CB—hematologic cancer	9.04e-06	0.00035	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PTEN—hematologic cancer	7.81e-06	0.000302	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—EP300—hematologic cancer	7.45e-06	0.000288	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—PIK3CA—hematologic cancer	5.51e-06	0.000213	CbGpPWpGaD
Fusidic Acid—ABCB11—Metabolism—AKT1—hematologic cancer	4.5e-06	0.000174	CbGpPWpGaD
